Diabetes drug ‘ups heart disease, death risk’
February 22nd, 2010 - 2:57 pm ICT by ANILondon, Feb 22 (ANI): US senators have linked a diabetes drug to heart disease and death.
They have claimed that the drug Avandia used by tens of thousands of Britons increases the risk of heart problems and could even lead to death, reports the Telegraph.
The US Food and Drug Administration (FDA), the medicines safety watchdog, has urged an advisory committee to verify the safety of Avandia.
The British equivalent, the MHRA, said it is “continuously monitoring” the safety of the drug.
In a report, senators Max Baucus and Charles Grassley alleged that the FDA had not banned the drug because it was too “cozy” with drugs firms.
They quoted a memo written by two FDA reviewers, which concluded: “The risks of (Avandia) are serious and exceed those for rival drug Actos.”
The reviewers said there was “strong evidence that (Avandia) confers an increased risk of” heart attack and heart failure when compared to Actos.
A 2007 study published in the Journal of the American Medical Association, showed that Avandia puts users at a 60 per cent greater risk of heart failure and a 29 per cent greater risk of death than other medication.
“Americans have a right to know there are serious health risks associated with Avandia and GlaxoSmithKline had a responsibility to tell them. Patients trust drugs companies with their health and their lives,” the Telegraph quoted Senator Baucus as saying.
However, a GSK spokesman said it dismissed the report’s conclusions.
The report “cherry-picks information from documents, which mischaracterises GlaxoSmithKline’s comprehensive efforts to research Avandia and communicate those findings to regulators, physicians and patients,” the company said.
The company said that it had rigorously studied Avandia’s safety and “consistently shared this data with regulators around the world”.
GSK said that it “does not condone any effort to silence scientific debate”. (ANI)
- Heart Risk Posed By Diabetes Drugs Avandia Same As Actos, Study Says - Aug 29, 2010
- The Diabetes Drugs, Avandia and Actos, Have The Same Amount of Risks - Aug 29, 2010
- Diabetes Drug Avandia Increases Heart Risk, Reviews Deduce - Jun 29, 2010
- Diabetes drug increases heart attack risks, say experts - Sep 06, 2010
- Avandia Under FDA Scanner - Feb 20, 2010
- FDA Adds A Warning About Liver Deterioration On Weight Loss Pills - May 27, 2010
- Anti-obesity drug's safety being reviewed amid liver damage fears - Aug 26, 2009
- Weight Loss Pills 'Alli' & 'Xenical' Get FDA Liver Damage Warning! - May 27, 2010
- Asthama Drugs Get New FDA Regulations - Feb 19, 2010
- Diabetes drug can raise heart disease risk by 25 percent - Mar 18, 2011
- Study: Diabetes drug increases heart risk - Jun 29, 2010
- Drug For Treatment Of Lupus On The Verge Of Being Approved By FDA - Nov 18, 2010
- Dr Reddy's acquires US-based oral penicillin facility - Nov 24, 2010
- Diabetes Drug Avandia Enhances The Risks Of Heart Disease - Jun 29, 2010
- Common Blood Pressure Drugs May Amplify The Risk Of Cancer - Jun 15, 2010
Tags: american medical association, avandia, british equivalent, charles grassley, death reports, death risk, diabetes drug, fda reviewers, food and drug administration, food and drug administration fda, heart disease death, heart failure, journal of the american medical association, london feb, max baucus, mhra, safety watchdog, senator baucus, us food and drug administration, us senators